CORRELATION OF PLASMA HEPARIN LEVELS WITH AUTOMATED CLOTTING TIMES DURING CARDIOPULMONARY BYPASS

被引:0
|
作者
BUTT, RW
LEBLANC, P
DERMODY, L
机构
来源
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:83 / 84
页数:2
相关论文
共 50 条
  • [41] PLASMA CHOLINESTERASE LEVELS DURING CARDIOPULMONARY BYPASS - A REPORT ON 10 CASES
    ROELOFSE, JA
    VANDERBIJL, P
    SOUTH AFRICAN MEDICAL JOURNAL, 1987, 71 (10): : 662 - 664
  • [42] epsilon-aminocaproic acid plasma levels during cardiopulmonary bypass
    BennettGuerrero, E
    Sorohan, JG
    Canada, AT
    Ayuso, L
    Newman, MF
    Reves, JG
    Mythen, MG
    ANESTHESIA AND ANALGESIA, 1997, 85 (02): : 248 - 251
  • [43] PLASMA VASOPRESSIN LEVELS AND URINARY ELECTROLYTE CONTENT DURING CARDIOPULMONARY BYPASS
    PHILBIN, DM
    COGGINS, CH
    AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (02): : 422 - 422
  • [44] PLASMA-LEVELS OF MAIN GRANULOCYTE COMPONENTS DURING CARDIOPULMONARY BYPASS
    RIEGEL, W
    SPILLNER, G
    SCHLOSSER, V
    HORL, WH
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1988, 95 (06): : 1014 - 1019
  • [45] PLASMA VASOPRESSIN LEVELS DURING CARDIOPULMONARY BYPASS WITH AND WITHOUT PROFOUND HEMODILUTION
    PHILBIN, DM
    COGGINS, CH
    CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1978, 25 (04) : 282 - 285
  • [46] Factors influencing activated clotting time following heparin administration for the initiation of cardiopulmonary bypass
    Satoshi Matsushita
    Akinori Kishida
    Yoshihito Wakamatsu
    Hiroshi Mukaida
    Hirohide Yokokawa
    Taira Yamamoto
    Atsushi Amano
    General Thoracic and Cardiovascular Surgery, 2021, 69 : 38 - 43
  • [47] Factors influencing activated clotting time following heparin administration for the initiation of cardiopulmonary bypass
    Matsushita, Satoshi
    Kishida, Akinori
    Wakamatsu, Yoshihito
    Mukaida, Hiroshi
    Yokokawa, Hirohide
    Yamamoto, Taira
    Amano, Atsushi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2021, 69 (01) : 38 - 43
  • [48] NEW HEPARIN ASSAY FOR ASSESSING HEPARIN REVERSAL DURING CARDIOPULMONARY BYPASS
    BICK, RL
    DUKES, ML
    WILSON, WL
    FEKETE, LF
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1978, 69 (02) : 204 - 204
  • [49] Change in Heparin Potency and Effects on the Activated Clotting Time in Children Undergoing Cardiopulmonary Bypass
    Guzzetta, Nina A.
    Amin, Sapan J.
    Tosone, Alexandra K.
    Miller, Bruce E.
    ANESTHESIA AND ANALGESIA, 2012, 115 (04): : 921 - 924
  • [50] Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass
    Nicholson, SC
    Keeling, DM
    Sinclair, ME
    Evans, RD
    BRITISH JOURNAL OF ANAESTHESIA, 2001, 87 (06) : 844 - 847